{"id":9972,"date":"2022-11-08T15:44:23","date_gmt":"2022-11-08T14:44:23","guid":{"rendered":"https:\/\/irlab.se\/q3-interim-report-broadcast\/"},"modified":"2022-11-08T15:46:33","modified_gmt":"2022-11-08T14:46:33","slug":"q3-interim-report-broadcast","status":"publish","type":"post","link":"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/","title":{"rendered":"Q3-rapport och presentation"},"content":{"rendered":"\n

Del\u00e5rsrapporten publiceras p\u00e5 onsdag 9 november kl 07:00 CET.<\/p>\n\n\n\n

Presentationen kommer att h\u00e5llas kl 10:00 CET den 9 november, 2022, p\u00e5 Infront Direkt Studio p\u00e5 Kungsgatan 33 i Stockholm. VD Richard Godfrey, EVP och Head of R&D Nicholas Waters och CFO Viktor Siewertz kommer att kommentera del\u00e5rsrapporten f\u00f6r perioden januari-september 2022. Presentationen h\u00e5lls p\u00e5 engelska och f\u00f6ljs av m\u00f6jligheten att st\u00e4lla fr\u00e5gor.<\/p>\n\n\n\n

Det \u00e4r ocks\u00e5 m\u00f6jligt att f\u00f6lja presentationen digitalt p\u00e5 https:\/\/youtu.be\/3gMDBBbrTW4<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Del\u00e5rsrapporten publiceras p\u00e5 onsdag 9 november kl 07:00 CET. Presentationen kommer att h\u00e5llas kl 10:00 CET den 9 november, 2022, p\u00e5 Infront Direkt Studio p\u00e5 Kungsgatan 33 i Stockholm. VD Richard Godfrey, EVP och Head of R&D Nicholas Waters och CFO Viktor Siewertz kommer att kommentera del\u00e5rsrapporten f\u00f6r perioden januari-september 2022. Presentationen h\u00e5lls p\u00e5 engelska […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[20],"tags":[],"class_list":["post-9972","post","type-post","status-publish","format-standard","hentry","category-kalender-2"],"acf":[],"yoast_head":"\nQ3-rapport och presentation - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Q3-rapport och presentation - IRLAB\" \/>\n<meta property=\"og:description\" content=\"Del\u00e5rsrapporten publiceras p\u00e5 onsdag 9 november kl 07:00 CET. Presentationen kommer att h\u00e5llas kl 10:00 CET den 9 november, 2022, p\u00e5 Infront Direkt Studio p\u00e5 Kungsgatan 33 i Stockholm. VD Richard Godfrey, EVP och Head of R&D Nicholas Waters och CFO Viktor Siewertz kommer att kommentera del\u00e5rsrapporten f\u00f6r perioden januari-september 2022. Presentationen h\u00e5lls p\u00e5 engelska […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-08T14:44:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-08T14:46:33+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/irlab.se\/#\/schema\/person\/f1a6ec2b5cf16bc3c6d2c8a3cc3b536d\"},\"headline\":\"Q3-rapport och presentation\",\"datePublished\":\"2022-11-08T14:44:23+00:00\",\"dateModified\":\"2022-11-08T14:46:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/\"},\"wordCount\":86,\"commentCount\":0,\"articleSection\":[\"Kalender\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/\",\"url\":\"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/\",\"name\":\"Q3-rapport och presentation - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2022-11-08T14:44:23+00:00\",\"dateModified\":\"2022-11-08T14:46:33+00:00\",\"author\":{\"@id\":\"https:\/\/irlab.se\/#\/schema\/person\/f1a6ec2b5cf16bc3c6d2c8a3cc3b536d\"},\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Q3-rapport och presentation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/irlab.se\/#\/schema\/person\/f1a6ec2b5cf16bc3c6d2c8a3cc3b536d\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\/\/irlab.se\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ca9ac6d5cafa1146003fcfd4a534f2590f937c279a5018bd860f6451bcacc0a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ca9ac6d5cafa1146003fcfd4a534f2590f937c279a5018bd860f6451bcacc0a5?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/irlab.se\/sv\/author\/irlab-user\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Q3-rapport och presentation - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/","og_locale":"sv_SE","og_type":"article","og_title":"Q3-rapport och presentation - IRLAB","og_description":"Del\u00e5rsrapporten publiceras p\u00e5 onsdag 9 november kl 07:00 CET. Presentationen kommer att h\u00e5llas kl 10:00 CET den 9 november, 2022, p\u00e5 Infront Direkt Studio p\u00e5 Kungsgatan 33 i Stockholm. VD Richard Godfrey, EVP och Head of R&D Nicholas Waters och CFO Viktor Siewertz kommer att kommentera del\u00e5rsrapporten f\u00f6r perioden januari-september 2022. Presentationen h\u00e5lls p\u00e5 engelska […]","og_url":"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/","og_site_name":"IRLAB","article_published_time":"2022-11-08T14:44:23+00:00","article_modified_time":"2022-11-08T14:46:33+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"admin","Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/#article","isPartOf":{"@id":"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/"},"author":{"name":"admin","@id":"https:\/\/irlab.se\/#\/schema\/person\/f1a6ec2b5cf16bc3c6d2c8a3cc3b536d"},"headline":"Q3-rapport och presentation","datePublished":"2022-11-08T14:44:23+00:00","dateModified":"2022-11-08T14:46:33+00:00","mainEntityOfPage":{"@id":"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/"},"wordCount":86,"commentCount":0,"articleSection":["Kalender"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/","url":"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/","name":"Q3-rapport och presentation - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2022-11-08T14:44:23+00:00","dateModified":"2022-11-08T14:46:33+00:00","author":{"@id":"https:\/\/irlab.se\/#\/schema\/person\/f1a6ec2b5cf16bc3c6d2c8a3cc3b536d"},"breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/q3-interim-report-broadcast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"Q3-rapport och presentation"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Person","@id":"https:\/\/irlab.se\/#\/schema\/person\/f1a6ec2b5cf16bc3c6d2c8a3cc3b536d","name":"admin","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/irlab.se\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ca9ac6d5cafa1146003fcfd4a534f2590f937c279a5018bd860f6451bcacc0a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca9ac6d5cafa1146003fcfd4a534f2590f937c279a5018bd860f6451bcacc0a5?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/irlab.se\/sv\/author\/irlab-user\/"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/9972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=9972"}],"version-history":[{"count":1,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/9972\/revisions"}],"predecessor-version":[{"id":9974,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/9972\/revisions\/9974"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=9972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/categories?post=9972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/tags?post=9972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}